A man managing urinary urgency while taking several prescribed medications for other conditions is quite possibly making his bladder symptoms worse with something his GP prescribed for something else entirely. This interaction is well documented in the clinical literature. It is almost never discussed at the point of prescribing.

The BJGP's practical guide to OAB in men states explicitly that a thorough medication review is part of the assessment of male OAB (Millman et al., 2018). In practice, the GP reviewing a man's antihypertensives rarely asks about bladder symptoms at the same visit.

Drugs that make it worse

Diuretics: furosemide, bendroflumethiazide. Prescribed for hypertension and heart failure. Increase urine production directly. If you take a diuretic in the evening, moving it to the morning can significantly reduce nocturnal urgency without changing the medication itself. Worth raising with your prescriber.

ACE inhibitors: ramipril, lisinopril. Cause a chronic dry cough in 10-20% of men. Chronic cough creates repeated intra-abdominal pressure spikes, worsening stress incontinence by the same mechanical pathway as heavy lifting. ARBs, including losartan, are an alternative class without the cough side effect.

Alpha-blockers: tamsulosin, doxazosin. Used to treat BPH and prostate symptoms, but can worsen stress leakage or urgency as a side effect. Prescribed for one problem, contributing to another.

Sedatives and antihistamines: promethazine, diphenhydramine. Reduce awareness of bladder signals and slow mobility. Increase risk of nocturnal accidents and delayed response to urgency.

Opioids. Cause urinary retention. When the bladder fills past capacity, overflow incontinence results. A continuous dribble that is often misattributed to OAB and treated incorrectly.

Antidepressants and antipsychotics. Affect bladder muscle and sphincter tone variably. Can cause both retention and urgency depending on the specific agent.

NSAIDs: ibuprofen, naproxen. Can cause urinary retention and worsen OAB symptoms in some men, particularly with regular use.

The polypharmacy problem

Men over 60 commonly take four or more regular medications. The BJGP review notes that polypharmacy makes isolating which drug is contributing to bladder symptoms genuinely difficult. Where multiple candidates exist, a structured medication review (assessing each drug's bladder relevance against its clinical necessity) is the appropriate step. This rarely happens without the patient explicitly raising it.

If you are on multiple medications and your bladder symptoms have worsened, the connection is worth investigating. It will not be volunteered. You have to ask.

Drugs that treat OAB

For men whose OAB symptoms are not adequately managed with lifestyle changes and bladder training, pharmacological options exist and work. The BJGP review is explicit: monotherapy with antimuscarinics or beta-3 agonists is safe and effective in men with predominant OAB. Prostate medications are not always required first (Millman et al., 2018).

Antimuscarinics: solifenacin, fesoterodine, darifenacin, tolterodine. Relax the detrusor muscle, reducing urgency. The BJGP recommends avoiding oxybutynin IR, which has the highest anticholinergic side effect burden including dry mouth, constipation, and cognitive effects in older men. Preferred agents are fesoterodine or darifenacin.

Beta-3 agonists: mirabegron, brand name Betmiga. Relax the bladder via a different pathway with fewer anticholinergic side effects. NICE-approved (TA290). Increasingly preferred in older men due to better tolerability. If antimuscarinics have not suited you, this is the alternative worth asking about.

Desmopressin. Reduces overnight urine production by temporarily replacing ADH. Specifically for nocturia. Effective and well-tolerated when sodium levels are monitored appropriately.

5-alpha reductase inhibitors: finasteride, dutasteride. Reduce prostate size over months. Improve flow rather than urgency directly. Takes six to twelve months to show full effect.

The two questions worth asking your GP

First: are any of my current medications known to affect bladder function?

Second: if OAB is the primary diagnosis, is an antimuscarinic or beta-3 agonist appropriate before or instead of prostate-focused treatment?

Going into a GP appointment with a specific question rather than a general complaint is considerably more likely to produce a useful clinical conversation. The NHS OAB treatment overview and the British National Formulary are both publicly accessible if you want to prepare.